logo for Tscan Therapeutics

Tscan Therapeutics

Business Services · Massachusetts, United States · 161 Employees

View Company Info for Free

About

Headquarters

830 Winter St, Waltham, Massachusetts, 02451, U...

Phone Number

(857) 399-9500

Revenue

$14.8 Million

Stock Symbol

TCRX

Industry

Business Services General Business Services

Most Recent Scoops

Jun 10 2024
Open Position
May 22 2024
Hiring Plans
Tscan Therapeutics has more open roles in Medical & Health than it has had at any time in the past 9 months.
See all scoops

Highlights

$345.5M

Total Funding Amount

$60M

Most Recent Funding Amount

5

Number of Funding Rounds

Who is Tscan Therapeutics

TScan is a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The Company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to build its ImmunoBank, one of the most extensive collections of known and novel solid tumor targets across different HLA types in the TCR field.Read more

Tscan Therapeutics's Social MediaPopular Searchestscan therapeutics IncTScan TherapeuticsEssential Therapeutics IncSkan Port IncEssentialtherapeutics.com.auSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: TCRXShow more

Tscan Therapeutics Org Chart

Gavin MacBeath

Acting Chief Executive Officer & Chief Operat...

PhoneEmail
Justin McCure

Chief Technology Officer

PhoneEmail
Jason Amello

Chief Financial Officer & Treasurer

PhoneEmail

PhoneEmail

Is Tscan Therapeutics your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to Tscan Therapeutics

See more similar companies
Illustration of an envelope

Tscan Therapeutics Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateSep 12, 2022
RoundDebt
Amount$60M
InvestorsK2 HealthVentures
Funding DateJul 16, 2021
RoundShare Placement
Amount$100M
Investors
Funding DateJan 25, 2021
RoundSeries C
Amount$100M
InvestorsRA Capital Management LP, BlackRock
See More

$345.5M

Total Funding Amount

$60M

Most Recent Funding Amount

5

Number of Funding Rounds

Tscan Therapeutics Tech Stack

A closer look at the technologies used by Tscan Therapeutics

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Most Recent Scoops

Jun 10 2024
Open Position
May 23 2024
Earnings
Earnings
May 22 2024
Hiring Plans
Tscan Therapeutics has more open roles in Medical & Health than it has had at any time in the past 9 months.
May 14 2024
Earnings
May 14 2024
Earnings
See more scoops

Tscan Therapeutics News & Media

Read more news

Frequently Asked Questions Regarding Tscan Therapeutics

Where is Tscan Therapeutics located?
Tscan Therapeutics's headquarters are located at 830 Winter St, Waltham, Massachusetts, 02451, United States
What is Tscan Therapeutics's phone number?
Tscan Therapeutics's phone number is (857) 399-9500
What is Tscan Therapeutics's stock symbol?
Tscan Therapeutics's stock symbol is TCRX
What is Tscan Therapeutics's official website?
Tscan Therapeutics's official website is www.tscan.com
What is Tscan Therapeutics's Revenue?
Tscan Therapeutics's revenue is $14.8 Million
What is Tscan Therapeutics's SIC code?
Tscan Therapeutics's SIC: 87,873
What is Tscan Therapeutics's NAICS code?
Tscan Therapeutics's NAICS: 54,541
How many employees does Tscan Therapeutics have?
Tscan Therapeutics has 161 employees
What industry does Tscan Therapeutics belong to?
Tscan Therapeutics is in the industry of: Business Services General, Business Services
What is Tscan Therapeutics competition?
Tscan Therapeutics top competitors include: TCR2 Therapeutics, Eureka Therapeutics, Cabaletta Bio, Arcellx
What technology does Tscan Therapeutics use?
Some of the popular technologies that Tscan Therapeutics uses are: WordPress.org, Drupal, PHP, New Relic Browser
Who is the CEO of Tscan Therapeutics?
Tscan Therapeutics's CEO is Gavin MacBeath
Who is the CFO of Tscan Therapeutics?
Tscan Therapeutics's CFO is Jason Amello
Who is the CTO of Tscan Therapeutics?
Tscan Therapeutics's CTO is Justin McCue
How do I contact Tscan Therapeutics?
Tscan Therapeutics contact info: Phone number: (857) 399-9500 Website: www.tscan.com
What does Tscan Therapeutics do?

TScan is a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The Company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to elimin... ate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to build its ImmunoBank, one of the most extensive collections of known and novel solid tumor targets across different HLA types in the TCR field.Read More

What are Tscan Therapeutics social media links?
Tscan Therapeutics Linkedin page Tscan Therapeutics Twitter page
How much funding has Tscan Therapeutics raised to date?
Tscan Therapeutics has raised $345.5 Million in 5 funding rounds
When was the last funding round for Tscan Therapeutics?
Tscan Therapeutics closed its last funding round on Sep 12, 2022 with the amount of $60 Million
Who invested in Tscan Therapeutics?
Tscan Therapeutics has 13 investors including Bessemer Venture Partners, GV, Longwood Fund and Novartis Institutes for BioMedical Research.
Is Tscan Therapeutics a public company?
Yes, Tscan Therapeutics is a public company and is traded under the symbol TCRX
See more information about Tscan Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.